BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 33183309)

  • 1. Perioperative strategy and outcome in giant retroperitoneal dedifferentiated liposarcoma-results of a retrospective cohort study.
    Bachmann R; Eckert F; Gelfert D; Strohäker J; Beltzer C; Ladurner R
    World J Surg Oncol; 2020 Nov; 18(1):296. PubMed ID: 33183309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
    Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
    World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivisceral resection for retroperitoneal liposarcoma-is it worth it? A 20-year single-center experience.
    Teixeira FR; Arakaki MS; Lima HVG; Ferreira FO; Menegozzo CAM; Silva ER; Montero EFS; Oya T; Lima LC; Akaishi EH; Utiyama EM
    Surg Today; 2023 Oct; 53(10):1181-1187. PubMed ID: 37606758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma.
    Willis F; Schimmack S; Uhl M; Haefner MF; Mechtersheimer G; Hinz U; Schmidt T; Debus J; Fröhling S; Schneider M
    Eur J Surg Oncol; 2020 May; 46(5):905-913. PubMed ID: 31892479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
    Singer S; Antonescu CR; Riedel E; Brennan MF
    Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.
    Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P
    J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal liposarcomas: the experience of a tertiary Asian center.
    Lee SY; Goh BK; Teo MC; Chew MH; Chow PK; Wong WK; Ooi LL; Soo KC
    World J Surg Oncol; 2011 Feb; 9():12. PubMed ID: 21284868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Re-resection for Locally Recurrent Retroperitoneal Liposarcoma at Four Years After Ex Vivo Tumor Resection and Autotransplantation of the Liver: A Case Report.
    Kobayashi T; Miura K; Ishikawa H; Soma D; Zhang Z; Yuza K; Hirose Y; Takizawa K; Nagahashi M; Sakata J; Kameyama H; Kosugi S; Wakai T
    Transplant Proc; 2016 May; 48(4):1215-7. PubMed ID: 27320590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of high-grade retroperitoneal liposarcomas: personal experience.
    Milone M; Pezzullo LS; Salvatore G; Pezzullo MG; Leongito M; Esposito I; Milone F
    Updates Surg; 2011 Jun; 63(2):119-24. PubMed ID: 21455814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease.
    Bautista N; Su W; O'Connell TX
    Am Surg; 2000 Sep; 66(9):832-6. PubMed ID: 10993610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
    Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
    J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
    Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
    Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retroperitoneal sarcomas: diagnostic and therapy].
    Gockel I; Oberholzer K; Gönner U; Mantai S; Junginger T
    Zentralbl Chir; 2006 Jun; 131(3):223-9. PubMed ID: 16739063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.
    Park JO; Qin LX; Prete FP; Antonescu C; Brennan MF; Singer S
    Ann Surg; 2009 Dec; 250(6):977-82. PubMed ID: 19953716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
    Erzen D; Sencar M; Novak J
    J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors predicting the postoperative survival period following treatment for primary retroperitoneal liposarcoma.
    Zhao X; Li P; Huang X; Chen L; Liu N; She Y
    Chin Med J (Engl); 2015 Jan; 128(1):85-90. PubMed ID: 25563319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma.
    Molina G; Hull MA; Chen YL; DeLaney TF; De Amorim Bernstein K; Choy E; Cote G; Harmon DC; Mullen JT; Haynes AB
    J Surg Oncol; 2016 Dec; 114(7):814-820. PubMed ID: 27634478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalizing surgical margins in retroperitoneal sarcomas.
    Callegaro D; Fiore M; Gronchi A
    Expert Rev Anticancer Ther; 2015 May; 15(5):553-67. PubMed ID: 25797538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of surgical margins in retroperitoneal sarcoma.
    Kirane A; Crago AM
    J Surg Oncol; 2016 Mar; 113(3):270-6. PubMed ID: 26707028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study.
    Selby LV; Clark EC; Liebner DA; Chen JL; Tinoco G; Bashian E; Beane JD; Pollock RE; Grignol VP
    Ann Surg Oncol; 2023 Nov; 30(12):7876-7881. PubMed ID: 37330448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.